Kenneth Frazier, Executive Chair, Director at Merck & Company, holds 111.11K shares in Eikon Therapeutics, Inc. (Ticker: EIKN), holds 705.13K shares in Merck & Company (Ticker: MRK), holds 40.50K shares in Exxon Mobil (Ticker: XOM). Most recently, Kenneth Frazier Bought ― shares of Eikon Therapeutics, Inc. on Feb 06, 2026 for an estimated value of $2.00M.
What is the percentage of profitable transactions made by Kenneth Frazier?
The percentage of profitable transactions made by Kenneth Frazier is 0%.
What is the average return per transaction made by Kenneth Frazier?
The average return per transaction made by Kenneth Frazier is -13.70%.
What stocks does Kenneth Frazier hold?
Kenneth Frazier holds: MRK, EIKN, XOM stocks.
What was Kenneth Frazier’s latest transaction?
Kenneth Frazier latest transaction was an Informative Buy of $2.00M.
What was Kenneth Frazier's most profitable transaction?
Kenneth Frazier’s most profitable transaction was an Informative Sell of MRK stock on November 8, 2022. The return on the trade was -5.60%.
What is Kenneth Frazier's role in Merck & Company?
Kenneth Frazier's role in Merck & Company is Executive Chair, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.